CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 14, 2005--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company focused primarily on products for the treatment of acute and chronic pain, migraine, and other pain-related conditions, announced today that in a decision entered on November 10, 2005, the Superior Court for the County of Orange in the State of North Carolina dismissed in its entirety “with prejudice” the consolidated shareholder derivative lawsuit previously pending against certain of POZEN’s current and former directors and officers. The related class action lawsuit filed in the U.S. District Court for the Middle District of North Carolina is ongoing.
